ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,431.60
      -0.04%
      US Tech 100
      19,168.00
      0.52%
      Dow Jones
      38,589.16
      -0.15%
      Brent Oil
      82.055
      -0.09%
      Bitcoin
      66,586.96
      -0.08%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Aurinia Pharmaceuticals Inc (AUPH)

      7. Aurinia Pharmaceuticals Inc (AUPH) News

      AUPH

      Aurinia Pharmaceuticals (AUPH)

      Aurinia Pharmaceuticals Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:AUPH
      DateTimeSourceHeadlineSymbolCompany
      06/14/20245:25PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:AUPHAurinia Pharmaceuticals Inc
      06/14/202412:16PMBusiness WireAurinia Announces 2024 Annual General Meeting ResultsNASDAQ:AUPHAurinia Pharmaceuticals Inc
      06/05/20246:00AMBusiness WireAurinia Presents Safety and Efficacy Profile of LUPKYNIS® for People with Lupus Nephritis at European Alliance of Associations for Rheumatology (EULAR) Congress 2024NASDAQ:AUPHAurinia Pharmaceuticals Inc
      06/04/20245:30PMBusiness WireAurinia Addresses Dubious Proposals Put Forth by Lucien SelceNASDAQ:AUPHAurinia Pharmaceuticals Inc
      06/04/20245:25PMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:AUPHAurinia Pharmaceuticals Inc
      06/03/20246:30PMBusiness WireAurinia Provides Update on Proxy StatementNASDAQ:AUPHAurinia Pharmaceuticals Inc
      05/30/20246:00AMBusiness WireAurinia Will Attend 2024 Jefferies Global Healthcare ConferenceNASDAQ:AUPHAurinia Pharmaceuticals Inc
      05/22/20244:16PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AUPHAurinia Pharmaceuticals Inc
      05/22/20244:14PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AUPHAurinia Pharmaceuticals Inc
      05/22/20244:11PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AUPHAurinia Pharmaceuticals Inc
      05/22/20244:09PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AUPHAurinia Pharmaceuticals Inc
      05/22/20244:07PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AUPHAurinia Pharmaceuticals Inc
      05/14/20246:00AMBusiness WireAnalysis Showing LUPKYNIS® is a Cost-Effective Treatment for Lupus Nephritis Presented at National Kidney Foundation’s Spring Clinical Meeting 2024NASDAQ:AUPHAurinia Pharmaceuticals Inc
      05/09/20246:00AMBusiness WireAurinia Presents Data Reinforcing LUPKYNIS® Safety and Efficacy for People with Lupus Nephritis at Congress of Clinical Rheumatology East 2024NASDAQ:AUPHAurinia Pharmaceuticals Inc
      05/07/20246:00AMBusiness WireAurinia Will Attend 2024 RBC Capital Markets Global Healthcare ConferenceNASDAQ:AUPHAurinia Pharmaceuticals Inc
      05/02/20246:00AMBusiness WireAurinia Pharmaceuticals Reports First Quarter 2024 Financial and Operational ResultsNASDAQ:AUPHAurinia Pharmaceuticals Inc
      05/01/20246:00AMBusiness WireAurinia Underscores Enduring Commitment to People Living with Lupus Nephritis Through Innovative Advocacy and Education Initiatives for Lupus Awareness MonthNASDAQ:AUPHAurinia Pharmaceuticals Inc
      04/30/20246:00AMBusiness WireThe U.S. Food & Drug Administration (FDA) Approves Updated LUPKYNIS® (voclosporin) Label to include Long-Term Data from the AURORA Clinical ProgramNASDAQ:AUPHAurinia Pharmaceuticals Inc
      04/16/202410:48AMBusiness WireUPDATE: New Aurinia Presentation Details at the 2024 Bloom Burton & Co. Healthcare Investor ConferenceNASDAQ:AUPHAurinia Pharmaceuticals Inc
      04/15/20246:00AMBusiness WireAurinia Pharmaceuticals to Release First Quarter Financial and Operational Results on May 2, 2024NASDAQ:AUPHAurinia Pharmaceuticals Inc
      04/09/20246:00AMBusiness WireAurinia Will Attend 2024 Bloom Burton & Co. Healthcare Investor ConferenceNASDAQ:AUPHAurinia Pharmaceuticals Inc
      03/07/20244:44PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AUPHAurinia Pharmaceuticals Inc
      03/07/20244:43PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AUPHAurinia Pharmaceuticals Inc
      03/07/20244:42PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AUPHAurinia Pharmaceuticals Inc
      03/07/20244:41PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AUPHAurinia Pharmaceuticals Inc
      02/29/20244:10PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:AUPHAurinia Pharmaceuticals Inc
      02/29/20248:30AMBusiness WireAurinia Receives Exemptive Relief from Canadian Securities Regulators for Share Repurchase ProgramNASDAQ:AUPHAurinia Pharmaceuticals Inc
      02/27/20248:30AMBusiness WireAurinia to Participate in Upcoming Investor Healthcare ConferencesNASDAQ:AUPHAurinia Pharmaceuticals Inc
      02/22/20244:35PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AUPHAurinia Pharmaceuticals Inc
      02/22/20244:33PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AUPHAurinia Pharmaceuticals Inc
       Showing the most relevant articles for your search:NASDAQ:AUPH

      Your Recent History

      KOSPI
      005180
      Binggrae
      Delayed Upgrade Clock